Foghorn Therapeutics Company
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2015
Employees Number:
51-100
Funding Status:
IPO
Total Funding:
111000000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership